Description
PT-141
PT-141, known generically as bremelanotide, is a synthetic peptide and melanocortin receptor agonist. It is FDA-approved under the brand name Vyleesi to treat hypoactive sexual desire disorder in premenopausal women. Unlike standard erectile dysfunction drugs, it acts directly on the central nervous system to stimulate sexual arousal.




